Discover 1,298 paid clinical trials in Mesa, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,298
Active & Responsive
Caris Biorepository Research Protocol
for
Cancer, Early Detection of Cancer, Minimal Residual Disease
Location: Scottsdale AZ, Santa Fe NM, Amarillo TX, Bend OR,
Sponsor: Caris Science, Inc.
Sex: All
Age: 18+
Code: NCT01499394
Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
for
Obesity, Overweight, Diabetes Mellitus, Type 2
Location: Gilbert AZ, Las Vegas NV, La Mesa CA, Pomona CA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684144
Phase 3, Recruiting
Active & Responsive
Study of GalaFLEX LITE⢠Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
for
Capsular Contracture Associated With Breast Implant,
Location: Scottsdale AZ, San Diego CA, El Paso TX,
Sponsor: C. R. Bard
Sex: Female
Age: 22 - 70
Code: NCT05945329
Recruiting
Active & Responsive
Phase 3 Pivotal Trial Comparing CARTISTEMĀ® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
for
Knee Cartilage Defects
Location: Tempe AZ, Scottsdale AZ, La Jolla CA, La Mesa CA,
Sponsor: Medipost, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07339111
Phase 3, Recruiting
Active & ResponsiveNew
A Study to Evaluate the Cariostatic Efficacy of Nano Silver Fluoride (NSF) vs. Silver Diamine Fluoride (SDF) in Children
for
Dental Caries
Location: Mesa AZ
Sponsor: A.T. Still University of Health Sciences
Sex: All
Age: 6 - 10
Code: NCT07861321
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Assessment of CCM in HF With Higher Ejection Fraction
for
Heart Failure, Heart Failure With Preserved Ejection Fraction,
Location: Mesa AZ, Scottsdale AZ, Tuscon AZ, La Jolla CA,
Sponsor: Impulse Dynamics
Sex: All
Age: 18+
Code: NCT05064709
Recruiting
Active & Responsive
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
for
Graves' Disease
Location: Gilbert AZ, Tucson AZ, La Mesa CA, El Paso TX,
Sponsor: Yarrow Bioscience, Inc.
Sex: All
Age: 18+
Code: NCT07682896
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult Participants
for
Healthy Participants
Location: Tempe AZ
Sponsor: Incyte Corporation
Sex: All
Age: 18 - 55
Code: NCT07448155
Phase 1, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Chandler AZ, Scottsdale AZ, Sun City AZ, Tucson AZ,
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
52-week Open Label Safety-Tolerability Study
for
Schizophrenia
Location: Chandler AZ, Las Vegas NV, San Diego CA, Anaheim CA,
Sponsor: LB Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07369154
Phase 3, Recruiting
Active & Responsive
Study of DONQ52 in Active Celiac Disease
for
Celiac Disease
Location: Chandler AZ, Scottsdale AZ, Litchfield AZ, Las Vegas NV,
Sponsor: Chugai Pharmaceutical
Sex: All
Age: 18 - 70+
Code: NCT07239336
Phase 2, Recruiting
Active & Responsive
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
for
Endometriosis
Location: Chandler AZ, Burbank CA, Forest Hill IN, Columbus GA,
Sponsor: Aspira Women's Health
Sex: Female
Age: 14 - 50
Code: NCT05245695
Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
for
Asthma
Location: Chandler AZ, Henderson NV, Newport Beach CA,
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT06977581
Phase 2, Recruiting
Active & Responsive
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Location: Chandler AZ, Peoria AZ, Sun City AZ, Gilbert AZ,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07165028
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Chandler AZ, Scottsdale AZ, Peoria AZ, Tucson AZ,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Chandler AZ, Peoria AZ, Tucson AZ, Las Vegas NV,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
for
Overweight, Obesity
Location: Chandler AZ, Scottsdale AZ, Tucson AZ, Las Vegas NV,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07589608
Phase 2, Recruiting
Active & Responsive
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for
Obesity or Overweight
Location: Chandler AZ, Sun City AZ, Sun City West AZ,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07575399
Phase 3, Recruiting
Active & Responsive
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
for
Obesity, Overweight
Location: Chandler AZ, Scottsdale AZ, Tucson AZ, Las Vegas NV,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06143956
Phase 2, Recruiting
Active & ResponsiveNew
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function